Tag: Europe
-
Messenger RNA Developer ETF Launches
A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA.
-
$180M Venture Fund Backing Age-Related Disease Start-Ups
A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics.
-
Plant-Based Protein Biotech Raises $3M in Seed Funds
A biotechnology start-up producing proteins with more sustainable and less costly plant-based processes is raising $3 million in its seed funding round.
-
Regeneron Gains Cancer, Infectious Disease Immunotherapies
A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion.
-
Novo Nordisk Buys RNA Biotech in $3.3B Deal
Global drug maker Novo Nordisk is acquiring biotechnology company Dicerna Pharmaceuticals Inc. in an all-cash deal valued at $3.3 billion.
-
Trial Identifies Biomarkers for Quick Concussion Test
A clinical trial reveals glycan compounds found in saliva and urine as indicators of traumatic brain injury, helping create a quick diagnostic for the condition.
-
Alphabet Forms AI Drug Discovery Company
Alphabet, the parent company of Google, is forming a new enterprise using artificial intelligence techniques to discover new protein-based drugs.
-
Hydrogel Obesity Capsule Shown to Protect Gut Tissue
Lab tests show an ingestible hydrogel designed to encourage weight loss by acting like raw vegetables helps protect and regulate intestinal tissue.
-
AI Analysis Finds Serious Covid-19 Genetic Driver
A deep and multi-variable analysis of patients with serious Covid-19 respiratory symptoms finds the condition associated with abnormal expression of one gene.
-
Infographic – Q3 2021 Venture Funds Continue Banner Year
Venture investors worldwide continue to look past the pandemic as investments in start-up enterprises rose to new levels in the U.S., Asia, and elsewhere.